Sandy Srinivas

Sandy Srinivas

UNVERIFIED PROFILE

Are you Sandy Srinivas?   Register this Author

Register author
Sandy Srinivas

Sandy Srinivas

Publications by authors named "Sandy Srinivas"

Are you Sandy Srinivas?   Register this Author

100Publications

3199Reads

39Profile Views

Application of pharmacoeconomics to formulary management in a health system setting.

Am J Health Syst Pharm 2019 Feb;76(6):381-386

Stanford University, Department of Medicine-Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajhp/zxy010DOI Listing
February 2019

Systemic Therapy for Advanced Urothelial Carcinoma: Current Standards and Treatment Considerations.

Am Soc Clin Oncol Educ Book 2018 May;38:342-353

From the Stanford University School of Medicine/Stanford Cancer Center, Stanford, CA; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medicine, Division of Oncology, Stanford University School of Medicine/Stanford Cancer Center, Stanford, CA; Department of Medicine, Division of Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_201193DOI Listing
May 2018

Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease.

Res Rep Urol 2018 26;10:7-16. Epub 2018 Jan 26.

Department of Oncology, Stanford University School of Medicine/Stanford Cancer Center, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/RRU.S125635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790095PMC
January 2018

Consolidative Radiotherapy in Metastatic Urothelial Cancer.

Clin Genitourin Cancer 2017 12 12;15(6):685-688. Epub 2017 Apr 12.

Division of Oncology, Stanford Hospital, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.04.007DOI Listing
December 2017

Recommendations for the Management of Rare Kidney Cancers.

Eur Urol 2017 12 16;72(6):974-983. Epub 2017 Jul 16.

Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.06.040DOI Listing
December 2017

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.

J Clin Oncol 2017 11 30;35(31):3525-3528. Epub 2017 Aug 30.

Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Christian K. Kollmannsberger, University of British Columbia, Vancouver, British Columbia, Canada; Bruce J. Roth, Washington University School of Medicine, St Louis, MO; Claudio Jeldres, Sherbrooke University, Sherbrooke, Quebec, Canada; Silke Gillessen, Kantonsspital, St Gallen, Switzerland; Karim Fizazi, University of Paris Sud, Paris, France; Siamak Daneshmand, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA; William T. Lowrance, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Nasser H. Hanna, Indiana University School of Medicine, Indianapolis, IN; Gabriella Cohn Cedermark, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden; Darren R. Feldman, Memorial Sloan Kettering Cancer Center and Weill Medical Cornell Medical College, New York, NY; Thomas Powles, Barts Cancer Institute, St Bartholomew's Hospital, Queen Mary University of London, London, United Kingdom; Mark A. Lewis, Intermountain Health, Salt Lake City, UT; Peter Scott Grimison, University of Sydney, Sydney, New South Wales, Australia; Douglas Bank, Testicular Cancer Resource Center, Riverwoods, IL; Christopher Porter, Virginia Mason Medical Center, Seattle, WA; Peter Albers, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany; Maria De Santis, Cancer Research Center, University of Warwick, Coventry, United Kingdom; Sandy Srinivas, Stanford University School of Medicine, Stanford, CA; George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Craig R. Nichols, Precision Genomics Cancer Research Clinic, Intermountain Health, Salt Lake City, UT; Testicular Cancer Commons, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.4723DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791831PMC
November 2017

Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma.

Eur Urol 2017 10 14;72(4):557-564. Epub 2017 Apr 14.

Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.03.046DOI Listing
October 2017

Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma.

PLoS One 2016 28;11(4):e0153321. Epub 2016 Apr 28.

Department of Radiology, Division of Nuclear Medicine, Stanford University School of Medicine, Stanford, CA, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153321PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849767PMC
February 2017

Incorporating VEGF-targeted therapy in advanced urothelial cancer.

Ther Adv Med Oncol 2017 Jan 16;9(1):33-45. Epub 2016 Sep 16.

Division of Medical Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834016667179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298449PMC
January 2017

The effect of information on preferences for treatments of metastatic renal cell carcinoma.

Curr Med Res Opin 2016 11 11;32(11):1827-1838. Epub 2016 Aug 11.

d Pfizer , Sollentuna , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2016.1211521DOI Listing
November 2016

Phase II Study of Pazopanib and Paclitaxel in Patients With Refractory Urothelial Cancer.

Clin Genitourin Cancer 2016 10 12;14(5):432-437. Epub 2016 Mar 12.

Stanford Cancer Center, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.03.011DOI Listing
October 2016

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

J Clin Oncol 2016 Oct;34(30):3655-3663

Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Sabina Signoretti, and Toni K. Choueiri, Dana-Farber Cancer Institute; Wanling Xie, Rana R. McKay, Mark A. Preston, Eunyoung Cho, Sabina Signoretti, and Toni K. Choueiri, Brigham and Women's Hospital; Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Eunyoung Cho, David F. McDermott, Sabina Signoretti, and Toni K. Choueiri, Harvard Medical School; Mark A. Preston and Kathryn M. Wilson, Harvard School of Public Health; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Laurence Albiges, Gustave Roussy, Université Paris-Saclay, Villejuif, France; A. Ari Hakimi, Emily C. Zabor, Anders J. Skanderup, and Helena Furberg, Memorial Sloan Kettering Cancer Center, New York; Ronit Simantov and Xun Lin, Pfizer Oncology, New York, NY; Jae-Lyun Lee, University of Ulsan College of Medicine, Asan; Sun-Young Rha, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Sandy Srinivas, Stanford Cancer Institute, Stanford; Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Georg A. Bjarnason, Sunnybrook Odette Cancer Center, Toronto; Scott Ernst, London Health Sciences Center, London, Ontario; Lori A. Wood, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Daniel Y.C. Heng, Tom Baker Cancer Center; University of Calgary, Calgary, Alberta, Canada; Ulka N. Vaishamayan, Karmanos Cancer Center, Detroit, MI; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Takeshi Yuasa, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Aristotelis Bamias, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; and Eunyoung Cho, The Warren Alpert Medical School of Brown University; Brown University School of Public Health, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065111PMC
October 2016

Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable?

Eur Urol 2016 08 2;70(2):227-30. Epub 2016 Mar 2.

Department of Urology, Stanford University School of Medicine, Stanford, CA, USA; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838160021
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2016.02.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927398PMC
August 2016

Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.

Nat Rev Urol 2016 Jan 8;13(1):47-60. Epub 2015 Dec 8.

Division of Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305-5103, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrurol.2015.254
Publisher Site
http://dx.doi.org/10.1038/nrurol.2015.254DOI Listing
January 2016

Second-line therapies in metastatic urothelial carcinoma.

Hematol Oncol Clin North Am 2015 Apr 28;29(2):341-59, x. Epub 2015 Jan 28.

Department of Medicine, Stanford University School of Medicine, Blake Wilbur Drive, Stanford, CA 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.10.007DOI Listing
April 2015

Utilization of renal mass biopsy in patients with renal cell carcinoma.

Urology 2014 Apr 12;83(4):774-9. Epub 2014 Feb 12.

Department of Urology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Health Services, University of California, Los Angeles School of Medicine, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2013.10.073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972335PMC
April 2014

Reply: To PMID 24529583.

Urology 2014 Apr 12;83(4):779-80. Epub 2014 Feb 12.

Department of Urology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Health Services, University of California, Los Angeles School of Medicine, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2013.10.077DOI Listing
April 2014

Prostate cancer, version 1.2014.

J Natl Compr Canc Netw 2013 Dec;11(12):1471-9

From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0174DOI Listing
December 2013

Vaccination of castration-resistant prostate cancer patients with TroVax (MVA-5T4) in combination with docetaxel: a randomized phase II trial.

Cancer Immunol Immunother 2013 Sep 23;62(9):1511-20. Epub 2013 Jul 23.

Oxford BioMedica (UK) Ltd., The Medawar Centre, Oxford Science Park, Oxford, OX4 4GA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-013-1457-zDOI Listing
September 2013

A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer.

Invest New Drugs 2013 Aug 24;31(4):1044-50. Epub 2013 Feb 24.

Department of Solid Tumor Oncology, Cleveland Clinic, Taussig Cancer Institute, 9500 Euclid Ave R35, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-9940-0DOI Listing
August 2013

A phase II study of bevacizumab and everolimus as treatment for refractory metastatic renal cell carcinoma.

Clin Genitourin Cancer 2013 Jun 24;11(2):100-6. Epub 2013 Jan 24.

Stanford Cancer Institute, Division of Oncology, Stanford School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2012.12.002DOI Listing
June 2013

Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC).

Urol Oncol 2013 Apr 25;31(3):379-85. Epub 2011 Feb 25.

Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2011.01.005DOI Listing
April 2013

Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.

Onkologie 2012 24;35(10):588-91. Epub 2012 Sep 24.

Division of Medical Oncology, Stanford University, CA 94305, USA.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/342695
Publisher Site
http://dx.doi.org/10.1159/000342695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364670PMC
March 2013

The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients.

JACC Heart Fail 2013 Feb 4;1(1):72-8. Epub 2013 Feb 4.

Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2012.09.001DOI Listing
February 2013

Toxicities of targeted agents in advanced renal cell carcinoma.

Curr Clin Pharmacol 2011 Aug;6(3):181-8

Stanford University, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157488411797189442DOI Listing
August 2011

Pyoderma gangrenosum with the use of sunitinib.

J Clin Oncol 2011 Apr 10;29(10):e266-7. Epub 2011 Jan 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.32.6165DOI Listing
April 2011

The bevacizumab experience in advanced renal cell carcinoma.

Onco Targets Ther 2010 Oct 5;3:179-89. Epub 2010 Oct 5.

Division of Oncology, Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962304PMC
http://dx.doi.org/10.2147/ott.s8157DOI Listing
October 2010

A phase II study of docetaxel and oxaliplatin for second-line treatment of urothelial carcinoma.

Chemotherapy 2009 27;55(5):321-6. Epub 2009 Jul 27.

Division of Oncology, Stanford University School of Medicine, Stanford, California 94305-1205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000230695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814022PMC
December 2009

Increased hemoglobin associated with VEGF inhibitors in advanced renal cell carcinoma.

Cancer Invest 2009 Oct;27(8):851-6

Stanford University School of Medicine, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900902744528DOI Listing
October 2009

A phase II trial of calcitriol and naproxen in recurrent prostate cancer.

Anticancer Res 2009 Sep;29(9):3605-10

Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
September 2009

Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib.

Nat Rev Urol 2009 Jun;6(6):338-43

Division of Oncology, Stanford University Medical Center, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2009.84DOI Listing
June 2009

NCCN Task Force Report: Bone Health in Cancer Care.

J Natl Compr Canc Netw 2009 Jun;7 Suppl 3:S1-32; quiz S33-5

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047404PMC
http://dx.doi.org/10.6004/jnccn.2009.0076DOI Listing
June 2009

Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer.

Dermatoendocrinol 2009 Jan;1(1):7-11

Department of Medicine; Divisions of Endocrinology; Stanford University School of Medicine; Stanford, California USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715203PMC
http://dx.doi.org/10.4161/derm.1.1.7106DOI Listing
January 2009

The combination of thalidomide and capecitabine in metastatic renal cell carcinoma -- is not the answer.

Am J Clin Oncol 2008 Oct;31(5):417-23

Division of Medical Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318168ef47DOI Listing
October 2008

Continuous daily dosing of sunitinib in patients with metastatic renal cell cancer.

Onkologie 2008 Sep 12;31(8-9):432-3. Epub 2008 Aug 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000144179DOI Listing
September 2008

Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.

Cancer 2008 Jul;113(1):72-7

Department of Genitourinary Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23519DOI Listing
July 2008

Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.

Expert Rev Anticancer Ther 2007 Dec;7(12):1749-61

Fellow, Medical Oncology, Stanford University School of Medicine, Division of Medical Oncology, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.7.12.1749DOI Listing
December 2007

Acute pancreatitis associated with sorafenib.

South Med J 2007 Sep;100(9):909-11

Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SMJ.0b013e31813c695dDOI Listing
September 2007

Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancer.

Nutr Rev 2007 Aug;65(8 Pt 2):S113-5

Department of Medicine/Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Room S-025, Stanford, CA 94305-5103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1753-4887.2007.tb00335.xDOI Listing
August 2007

Bone related events in high risk prostate cancer.

J Urol 2006 Dec;176(6 Pt 2):S50-4

Division of Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2006.06.076DOI Listing
December 2006

Nonplatinum therapy in advanced bladder cancer.

Expert Rev Anticancer Ther 2006 Jun;6(6):887-94

Stanford University, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.6.887DOI Listing
June 2006

Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade.

Urology 2006 Jun;67(6):1229-34

Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305-5847, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2005.12.031DOI Listing
June 2006

Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer.

Urology 2006 May;67(5):1001-6

Division of Oncology, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2005.11.004DOI Listing
May 2006

A lower dose of thalidomide is better than a high dose in metastatic renal cell carcinoma.

BJU Int 2005 Sep;96(4):536-9

Division of Oncology, Stanford Medical Center, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2005.05680.xDOI Listing
September 2005